Navigation Links
New 12 Week, Interferon-Free Treatment Arms Added to All-Oral Combination Study of PSI-7977 and Daclatasvir (BMS-790052) for HCV Genotype 1
Date:11/4/2011

PRINCETON, N.J., Nov. 4, 2011 /PRNewswire/ -- Pharmasset, Inc. (Nasdaq: VRUS) and Bristol-Myers Squibb Company (NYSE: BMY) announced today the addition of four treatment arms to the ongoing Phase IIa trial evaluating the combination of Pharmasset's PSI-7977, a nucleotide polymerase inhibitor, and Bristol-Myers Squibb Company's daclatasvir (BMS-790052), an investigational NS5A replication complex inhibitor, for the treatment of chronic hepatitis C (HCV).  This trial is the result of a clinical collaboration agreement between Pharmasset and Bristol-Myers Squibb announced in January 2011.

"Recent data from Pharmasset's ELECTRON trial as well as other all-oral DAA combination studies have demonstrated the potential of 12 week treatment regimens," stated William Symonds, Pharmasset's Senior Vice President of Clinical Pharmacology and Translational Medicine. "This study will evaluate whether the potent antiviral activity and high barrier to resistance seen in Phase II studies of PSI-7977 may enable shorter treatment durations with an interferon-free regimen than the current standard of care."

"Hepatitis C is a rapidly evolving field of research.  As the science evolves, we are evolving our clinical development programs to continue to drive advances in HCV research," said Brian Daniels, senior vice president, Development, Bristol-Myers Squibb.  "Shorter duration, all-oral therapy and effective treatment options for patients who have failed approved triple therapy regimens are clear unmet medical needs in HCV.  With this study, we aim to understand the potential for daclatasvir to help address these needs, as part of a novel combination treatment regimen."

About the Trial

T
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Photos: SOS Childrens Villages Observes World Orphan Week, October 5-11, 2008
2. Neuroscience Researcher Has Positive Message for International Alzheimers Awareness Week, July 6 - 12: Even Though World Economy is Declining, Alzheimers Research is Advancing
3. Timberline Knolls Rejoices in Recovery During National Eating Disorder Awareness Week, Feb. 20-26
4. Roche Diabetes Care Celebrates Second Annual Infusion Site Awareness Week, Aug. 29-Sept. 4
5. Experis Recognizes National Healthcare IT Week, Provides Tips for ICD-10 Assessment Decision
6. Pharmasset Initiates QUANTUM, a Phase 2b Interferon-Free Trial of PSI-7977 and PSI-938 for All HCV Genotypes
7. Pharmasset Announces the Initiation of an Interferon-Free Phase 3 Program with PSI-7977 for HCV
8. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
11. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 24, 2014  Diplomat Pharmacy, Inc. (NYSE: ... pharmacy, is proud to announce Jennifer Hagerman , ... Diplomat, will take office as the president of the ... induction ceremony will take place Feb. 28, 2015, at ... held at the Renaissance Center in Detroit, ...
(Date:12/24/2014)... KENNEWICK, Wash. , Dec. 23, 2014 /PRNewswire/ ... stage development company engaged primarily in the development ... and therapeutic applications, today announced that it has ... the Food and Drug Administration ("FDA") for marketing ... to Section 513(f)(2) of the U.S. Food, Drug ...
(Date:12/24/2014)... , Dec. 23, 2014  Lockton Dunning ... of Lockton Companies, announced the addition of Vice ... will join Lockton Dunning,s Pharmacy Consulting team, Excelsior ... of relevant industry experience to the position.  Most ... Market Sales at Diplomat Specialty Pharmacy, where she ...
Breaking Medicine Technology:Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 2Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 3Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 2Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 3Kim Foerster Joins Lockton Companies 2
... 2012 Pernix Therapeutics Holdings, Inc. (NYSE Amex: ... the introduction of Omeclamox-Pak® , a ten-day therapy ... mg) and amoxicillin capsules (500 mg) for the treatment ... infection and duodenal ulcer disease (active or one-year history) ...
... leading events organizer UBM Live announced strong ... event for buyers and sellers of high value chemistry. ... show which takes place from February 19th to 22nd ... Major pharmaceutical, fine and specialty chemical companies that have ...
Cached Medicine Technology:Pernix Therapeutics Introduces Omeclamox-Pak®, First Product in Gastroenterology Portfolio 2Pernix Therapeutics Introduces Omeclamox-Pak®, First Product in Gastroenterology Portfolio 3Strong Booking Levels For Informex 2013 2Strong Booking Levels For Informex 2013 3
(Date:12/26/2014)... “Many people become overwhelmed by the thought ... and phone calls with insurance companies,” The Jones Firm ... free eBook on pedestrian and bicycle accidents . ... bicycle auto accident claims assures the injured individual that ... handling their case while they focus on recovering. ...
(Date:12/26/2014)... December 26, 2014 Parker & ... the best in heating, cooling and plumbing contractor ... hour emergency services in 2014 with regard to ... that Arizona is known for its incredibly hot ... understands the intricacies and details of a wide ...
(Date:12/25/2014)... December 26, 2014 The report ... to 2023” focuses on the current treatment landscape, ... the colorectal cancer market. Stivarga is a drug ... or rectal cancer. Boehringer Ingelheim is developing nintedanib ... treatment of refractory CRC in the US, Europe, ...
(Date:12/25/2014)... Recently, iFitDress.com, the popular online supplier of wedding dresses and ... of black one-shoulder cocktail dresses . In addition, all ... at discounted prices, up to 70% off. , ... weeks only. You know, we have thousands of frequent callers ... new items can visit our website for more details. The ...
(Date:12/25/2014)... 2014 BambooFlooringChina.com sells many bamboo products ... flooring. Today, the company announces big discounts on ... and colors. , BambooFlooringChina.com is the world’s leader in ... is valid until Jan. 20, 2015. , The bamboo ... with a natural thread. All the bamboo strips for ...
Breaking Medicine News(10 mins):Health News:Guide to Handling Pedestrian and Bicycle Accidents Released By The Jones Firm, Featured in Recent Article 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2
... 2010 In a major crackdown, Cambodia has forced ... country to close within the past five months. Led ... Substandard Medicines (IMC), the shops were targeted because of ... substandard and counterfeit medicines in the country. This evidence ...
... find , WEDNESDAY, April 28 (HealthDay News) -- Researchers ... disease caused by cystic fibrosis: Which comes first, infection ... to answer that question, and it looks like infection ... assistant professor of internal medicine at the University of ...
... Mouse study suggests Wnt protein might help humans with fractures, ... have found a way to significantly speed up the healing ... in humans, could mean people with fractures would be free ... huge implications," said Dr. Victor Khabie, co-director of the Orthopedic ...
... ... companies to put plans on hold in favor of protecting assets, cutting costs, and “waiting ... evidence that corporations are re-starting their strategic engines and getting back to a more typical ... Plano, ...
... ... ... to pay $520 million in civil fines, penalties and damages to settle allegations that ... its marketing and promotional practices for the blockbuster atypical antipsychotic Seroquel (U.S. ex rel. ...
... in making men masculine, research shows , WEDNESDAY, April 28 ... to testosterone in men and estrogen in women, but a ... cut. , The male hormone testosterone doesn,t work in ways ... brain during development and making males behave a certain way ...
Cached Medicine News:Health News:Cambodia takes action in fight against substandard and counterfeit medicines 2Health News:Cambodia takes action in fight against substandard and counterfeit medicines 3Health News:Pigs Yield Clues to Cystic Fibrosis-Related Lung Disease 2Health News:Scientists Find Way to Heal Broken Bones Faster 2Health News:Scientists Find Way to Heal Broken Bones Faster 3Health News:Leading Corporate Consulting Firm Says U.S. Companies are Re-focusing on Corporate Strategic Planning 2Health News:AstraZeneca Pays $520 Million to Settle Seroquel Whistleblower Claims 2Health News:AstraZeneca Pays $520 Million to Settle Seroquel Whistleblower Claims 3Health News:Typical Male Behavior Comes From Estrogen, Too 2
... NCP-1, was designed to maximize patient comfort ... the first ever to feature Vacuum Pump ... augmentation and reduces the "slamming" effect commonly ... treatment platform maintains patients comfort and security ...
... The Arctic Sun 2000 represents a ... The Arctic Sun System rapidly induces mild ... from therapeutic hypothermia or rapidly reduces temperature ... monitors and maintains core body temperature in ...
... Artic Sun 100 monitors and controls patient ... hypothermia associated with surgery, trauma, or other ... response to feedback provided from a patient ... ambient (room air) and 42C (107.6F) to ...
... its professional AED offeringthe G3 Pro. ... ECG color display, provides manual override ... most advanced technology available to provide ... for emergency treatment of sudden cardiac ...
Medicine Products: